Cargando…

Investigation of Biological Activities of Wild Bitter Melon (Momordica charantia Linn. Var. Abbreviata Ser.)

Wild bitter melon (Momordica charantia L. var. Abbreviata Ser.) is a wild edible variety of M. charantia, often used in folk medicine. In this study, the biological activities of its extract and fractions were investigated in vitro. It was found that ethyl acetate (EA) fraction exhibited high 1,1-di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Thi My Hanh, Ngo, Dai-Hung, Ngo, Dai-Nghiep, Vo, Thanh Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627102/ https://www.ncbi.nlm.nih.gov/pubmed/31151277 http://dx.doi.org/10.3390/biom9060211

Ejemplares similares

Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars
por: Tsai, Tsung-Hsien, et al.
Publicado: (2014)

Telomere-to-telomere genome assembly of bitter melon (Momordica charantia L. var. abbreviata Ser.) reveals fruit development, composition and ripening genetic characteristics
por: Fu, Anzhen, et al.
Publicado: (2022)

Effects of Storage Time and Temperature on Antioxidants in Juice from Momordica charantia L. and Momordica charantia L. var. abbreviata Ser.
por: Lin, Yung-Sheng, et al.
Publicado: (2020)

Supplementation with Hualian No. 4 wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) extract increases anti-fatigue activities and enhances exercise performance in mice
por: HSIAO, Chien-Yu, et al.
Publicado: (2017)

Influence of Total Anthocyanins from Bitter Melon (Momordica charantia Linn.) as Antidiabetic and Radical Scavenging Agents
por: Güdr, Aytaç
Publicado: (2016)

Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium
por: Czompa, Attila, et al.
Publicado: (2017)

A case of atrial fibrillation due to Momordica charantia (bitter melon)
por: Erden, Ismail, et al.
Publicado: (2010)

Diverse roles of bitter melon (Momordica charantia) in prevention of oral cancer
por: Sur, Subhayan, et al.
Publicado: (2021)

Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica charantia)
por: Cao, Heping, et al.
Publicado: (2014)

Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia)
por: Cuong, Do Manh, et al.
Publicado: (2018)

Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
por: Sur, Subhayan, et al.
Publicado: (2020)

Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice
por: Mohammadmoradi, Shayan, et al.
Publicado: (2020)

Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)
por: Hazarika, Ridip, et al.
Publicado: (2012)

Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
por: Nerurkar, Pratibha V, et al.
Publicado: (2011)

Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
por: Nerurkar, Pratibha V, et al.
Publicado: (2010)

The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress
por: Kim, Hyun Young, et al.
Publicado: (2013)

Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis
por: Semiz, Asli, et al.
Publicado: (2020)

Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products
por: AKYÜZ, Esin, et al.
Publicado: (2020)

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment
por: , Mahwish, et al.
Publicado: (2021)

Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (Momordica charantia) against Pancreatic Cancer
por: Kandhari, Kushal, et al.
Publicado: (2021)

Analgesic and antipyretic activities of Momordica charantia Linn. fruits
por: Patel, Roshan, et al.
Publicado: (2010)

Bitter Melon (Momordica charantia L.) Rootstock Improves the Heat Tolerance of Cucumber by Regulating Photosynthetic and Antioxidant Defense Pathways
por: Tao, Mei-Qi, et al.
Publicado: (2020)

An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia
por: Poolperm, Sutthaya, et al.
Publicado: (2017)

Analysis of the Complete Mitochondrial Genome of the Bitter Gourd (Momordica charantia)
por: Niu, Yu, et al.
Publicado: (2023)

Callogénesis y rizogénesis In Vitro de Momordica charantia Linn :
por: San Gabriel Guevara, Omar
Publicado: (2010)

Effects of drying conditions in low‐temperature microwave‐assisted drying on bioactive compounds and antioxidant activity of dehydrated bitter melon (Momordica charantia L.)
por: Nguyen, Thi‐Van‐Linh, et al.
Publicado: (2020)

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2011)

Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study
por: Saad, Dalia Yossri, et al.
Publicado: (2017)

Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model
por: Reed, Dominique, et al.
Publicado: (2021)

Correction: strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2014)

Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues
por: Bao, Bin, et al.
Publicado: (2013)

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation
por: Zeng, Yanmei, et al.
Publicado: (2018)

Momordica charantia (bitter melon) efficacy and safety on glucose metabolism in Korean prediabetes participants: a 12-week, randomized clinical study
por: Kim, Bukyung, et al.
Publicado: (2022)

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade
por: Yung, Mingo M. H., et al.
Publicado: (2015)

Potential Biomarkers of Peripheral and Central Fatigue in High-Intensity Trained Athletes at High-Temperature: A Pilot Study with Momordica charantia (Bitter Melon)
por: Kwak, Jae-Jun, et al.
Publicado: (2020)

Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis
por: Matsumura, Hideo, et al.
Publicado: (2014)

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)
por: Mahwish, et al.
Publicado: (2017)

Genome-Wide Analysis of Simple Sequence Repeats in Bitter Gourd (Momordica charantia)
por: Cui, Junjie, et al.
Publicado: (2017)

Comparison of biogenic silver nanoparticles formed by Momordica charantia and Psidium guajava leaf extract and antifungal evaluation
por: Nguyen, Dai Hai, et al.
Publicado: (2020)

Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia)
por: Kole, Chittaranjan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qp3j1fsv6id3mj7qkb12543h01